Takeda Pharmaceutical's Dividends Paid - Common fell 120.11% to -$968.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.9 billion, marking a year-over-year decrease of 201.86%. This contributed to the annual value of $2.0 billion for FY2025, which is 26.74% down from last year.
Takeda Pharmaceutical's Dividends Paid - Common amounted to -$968.2 million in Q4 2025, which was down 120.11% from -$59.6 million recorded in Q3 2025.
In the past 5 years, Takeda Pharmaceutical's Dividends Paid - Common registered a high of $5.3 billion during Q1 2021, and its lowest value of -$1.2 billion during Q2 2021.
For the 5-year period, Takeda Pharmaceutical's Dividends Paid - Common averaged around $580.6 million, with its median value being -$486.9 million (2021).
The largest annual percentage gain for Takeda Pharmaceutical's Dividends Paid - Common in the last 5 years was 2213.73% (2023), contrasted with its biggest fall of 1353.94% (2023).
Takeda Pharmaceutical's Dividends Paid - Common (Quarter) stood at -$1.2 billion in 2021, then rose by 21.05% to -$913.0 million in 2022, then fell by 2.44% to -$935.3 million in 2023, then decreased by 2.29% to -$956.7 million in 2024, then decreased by 1.2% to -$968.2 million in 2025.
Its last three reported values are -$968.2 million in Q4 2025, -$59.6 million for Q3 2025, and -$1.0 billion during Q2 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value